Mackenzie Financial’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Mackenzie Financial’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-420	Closed	-$4.93K	–	1630
2022 Q4	$4.93K	Hold	420	–	–	﹤0.01%	1421
2022 Q3	$9K	Sell	420 -32	-7%	-$863	﹤0.01%	1422
2022 Q2	$11K	Buy	452 +117	+35%	+$3.98K	﹤0.01%	1454
2022 Q1	$17K	Hold	335	–	–	﹤0.01%	1394
2021 Q4	$23K	Sell	335 -29	-8%	-$2.44K	﹤0.01%	1413
2021 Q3	$34K	Buy	+364	New	+$34.6K	﹤0.01%	1415

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mackenzie Financial's VBIV Position: Q1 2023 in Review

Mackenzie Financial sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2023, closing a stake of 420 shares — an estimated $4.93K sold.

Mackenzie Financial first reported a position in VBIV in Q3 2021 and held it in 6 quarters. The position peaked at $34K in Q3 2021. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

Mackenzie Financial reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2023 after selling out during the quarter.
Mackenzie Financial sold 420 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $4.93K.
Mackenzie Financial first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 6 quarters.
Mackenzie Financial's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $34K in Q3 2021.
95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.